INSIGHTS ON CLINICAL TRIAL PARTNERING

• Building Blocks For Strategic Patient Support In Clinical Trials

  Let’s talk about some tangible building blocks necessary to achieve the next evolution of patient support and explore the effects of strategic payment, budgeting, and logistics solutions.

• Switching IRT/RTSM Providers Shouldn't Feel Like Moving Mountains | Korio Makes It Easy

  Unveil how structured, repeatable processes can turn RTSM migrations from high‑risk undertakings into predictable transitions.

• Rare Diseases And The Integrated CDMO Support System

  Champion the rare‑disease community by advancing development models built on precision, continuity and global coordination that ensure every dose reaches the patients who need it most.

• Improving Site Efficiency With Automated Drug Resupply And Forecasting

  Interactive Response Technology (IRT) can transform site operations by replacing error-prone manual processes with real-time, automated systems that relieve some of the burden on trial sites.

• Single IRB Review: Tips For Sponsors And CROs Working With Institutional Sites

  11/7/2024

  Develop an understanding of the institutional IRB’s role and explore how sponsors and CROs can address the potential impact of mandated sIRB oversight and pave the way for smoother implementation.

• Early-Stage Biotech's AI Advantage Is A Window That Closes

  5/6/2026

  The "greenfield" advantage allows biotechs to build AI-native trials from the start, replacing manual data entry with automated workflows and structured human oversight for better data integrity.

• Paperless Online Remote Source Document Verification

  2/2/2026

  Learn how Clinical Trial Organizations, Monitoring Teams and Clinical Sites can benefit from the way Judi transforms rSDV from a logistical hurdle into a strategic asset.

• 5 Questions That Put Sponsors Back in Control of Bioanalysis Projects

  12/9/2025

  Bioanalysis service quality significantly impacts project success. Don't settle for typical CRO claims; demand better technology, pricing transparency, and dedicated partnership.

• New Purpose-Built Facility For Large-Scale Sterile Fill/Finish Operations

  7/17/2025

  Expanding capacity for late-phase clinical and large-scale commercial small molecule and biologic drugs, a new facility boosts sterile fill/finish capabilities.